Full profile

Also known asTheanine, N-ethyl-L-glutamine
Best forCalm focus · Taking the edge off caffeine · Settled attention during deep work
Evidence gradeGrade B · Moderate: several human trials, some mixed results
Studied dose range50–250 mg per serving across the trials cited here (Nobre 50 mg; Haskell 250 mg), most commonly 100–200 mg.
Time to effectOften reported within 30–60 minutes; acute rather than cumulative.
Best formPlain L-theanine. Suntheanine is a commonly referenced branded form.
Food sourcesGreen tea, Black tea

Evidence, honestly graded

Held at B on 2026-09-14; with Bacopa, it is one of the two B-graded actives in the Signal State Core concept formula. A 2026 meta-analysis of 31 randomized trials (Gerolymos et al.) found a single 200 mg dose improved attention and reaction-time measures versus placebo (SMD 0.51); its acute-stress effect was smaller and leaned on higher-risk-of-bias studies, and it found no effect on fatigue. A 2025 meta-analysis of sleep trials (Bulman et al.) found better self-rated sleep quality and daytime functioning, but no change on objective sleep measures. What keeps it short of A: the attention signal shows up mainly on reaction-time tasks rather than as a broad, all-day calm-focus effect, most trials are small, several are industry-linked, and a smaller 2025 meta-analysis of five trials in 148 healthy adults (Mátyus et al.) splits: it found a dose-dependent improvement in rapid visual information processing and recognition reaction time (−15.20 ms), but no effect on simple reaction time or Stroop performance. Positive acute trials cluster in the 100–250 mg range; Health Canada's monograph permits a relaxation claim only, at 200–250 mg/day.

See the full grading rubric (study type, replication, population match, and dose adequacy) in The Evidence Standard.

What the benefits research does and doesn't support, in depth: L-Theanine Benefits: What the Research Actually Supports.

1,656 natural health products with an active licence in Health Canada's LNHPD list L-Theanine as a medicinal ingredient.

That makes L-Theanine a recognized, licensable medicinal ingredient in Canada, regulated by Health Canada's Natural and Non-prescription Health Products Directorate, which issues each licensed natural health product a Natural Product Number (NPN). Search the LNHPD to verify.

Source: Health Canada Licensed Natural Health Products Database, snapshot 2026-09-28. A count of products with an active licence, not an endorsement of any health claim. This describes the ingredient's regulatory standing in Canada, not Signal State Core, which is a pre-launch concept and is not a licensed natural health product.

Side effects

  • Generally well tolerated in studies
  • Occasional reports of headache or lightheadedness

The full side-effect breakdown: L-Theanine Side Effects: What the Research Actually Shows.

Who should avoid it or check first

  • Pregnant or breastfeeding without clinician guidance
  • On blood-pressure medication without review

Interactions

  • May interact with blood-pressure and stimulant medications; discuss with a clinician

Stacks well with

Use caution stacking with

  • Sedatives without clinician guidance

What to look for on a label

  • Look for a stated milligram dose per serving, not a proprietary blend.
  • Branded forms should name the standardization on the label.

References

Grades and studied doses are our conservative reading of the human research, shown for education. They are not product claims, and a studied dose is not a recommended dose.

Revision history

Every change to this ingredient's evidence status, dated and explained. The full cross-library log lives at Evidence Updates.

  • 2026-09-17Citation review

    Corrected a one-sided description. This profile reported that the 2025 five-trial meta-analysis found no effect on simple reaction time or the Stroop test, which is true but leaves out that the same analysis found a dose-dependent improvement in rapid visual information processing and recognition reaction time. Both findings are now stated and the meta-analysis is cited in full, alongside a larger 2025 tea review whose Lipton and Unilever funding is disclosed. B holds.

  • 2026-09-14Citation review

    Held at B with two new meta-analyses added: a 2026 review of 31 RCTs found a single 200 mg dose improved attention and reaction time, and a 2025 review found improvements in self-rated, but not objectively measured, sleep.

  • 2026-07-07New profile

    Initial profile published at Grade B: multiple small human trials show acute calm and attention effects, often studied alongside caffeine, with modest and variable effect sizes.

See how L-Theanine compares on grade, dose, and goal in the Evidence Explorer.